stoxline Quote Chart Rank Option Currency Glossary
  
Pasithea Therapeutics Corp. (KTTA)
7.11  -0.01 (-0.14%)    04-19 16:00
Open: 7.11
High: 7.11
Volume: 518
  
Pre. Close: 7.12
Low: 7.11
Market Cap: 7(M)
Technical analysis
2024-04-19 5:10:37 PM
Short term     
Mid term     
Targets 6-month :  9.66 1-year :  10.8
Resists First :  8.27 Second :  9.25
Pivot price 7.7
Supports First :  6.7 Second :  5.57
MAs MA(5) :  7.16 MA(20) :  7.55
MA(100) :  7.19 MA(250) :  8.37
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  2.2 D(3) :  5.4
RSI RSI(14): 43.7
52-week High :  17.39 Low :  5.26
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ KTTA ] has closed above bottom band by 24.0%. Bollinger Bands are 2.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 7.13 - 7.16 7.16 - 7.19
Low: 7.01 - 7.06 7.06 - 7.1
Close: 7.04 - 7.12 7.12 - 7.17
Company Description

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Headline News

Mon, 15 Apr 2024
11 Undervalued Stocks for Less Than $50 in April 2024 - Investopedia

Tue, 13 Feb 2024
Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004 - GlobeNewswire

Tue, 02 Jan 2024
Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer ... - GlobeNewswire

Tue, 02 Jan 2024
Pasithea conducts 1-for-20 reverse stock split, gets FDA okay for study (NASDAQ:KTTA) - Seeking Alpha

Tue, 19 Dec 2023
Pasithea Therapeutics Announces Results from 2023 Annual Meeting - Yahoo Finance

Wed, 13 Dec 2023
Why Is Pasithea Therapeutics (KTTA) Stock Down 12% Today? - InvestorPlace

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 1 (M)
Shares Float 1 (M)
Held by Insiders 140.5 (%)
Held by Institutions 23.8 (%)
Shares Short 9 (K)
Shares Short P.Month 9 (K)
Stock Financials
EPS -12.65
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 22.45
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -28.1 %
Return on Equity (ttm) -47.1 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -14.75
Qtrly Earnings Growth 0 %
Operating Cash Flow -13 (M)
Levered Free Cash Flow -7 (M)
Stock Valuations
PE Ratio -0.57
PEG Ratio 0
Price to Book value 0.31
Price to Sales 0
Price to Cash Flow -0.56
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android